Investment Team
- Board Responsibilities
-
- Prior Board Participation
-
Matthew Rieke, M.D.
- Founding Principal of Quaker Partners and promoted to Partner in 2005
- Previously: Principal at Novitas Capital, a venture capital fund investing in early stage life science and IT companies. Created start-up companies based on Penn faculty inventions at the University of Pennsylvania Center for Technology Transfer. Management consultant with CSC Healthcare, focusing on disease management protocols. Researched novel therapeutics and bone marrow transplantation at Cedars-Sinai Medical Center.
- Board Responsibilities: Neotropix, Tarsa Therapeutics, TearScience and TransEnterix
- Other Investment Responsibilities: Durata Therapeutics, Neuronetics and RainDance Technologies
- Prior Board Participation: Biolex, BioRexis (acquired by Pfizer) and NB Therapeutics
- Other: Advisor for AdvaMed. Member of the Biotech and Life Sciences Advisory Committee for Ben Franklin Technology Partners of SE PA and the Life Sciences Greenhouse of Central PA.
- Education: B.A. from Colgate University, Doctor of Medicine from the University of Pennsylvania School of Medicine, M.B.A. from the Wharton School of the University of Pennsylvania. Maintains active medical license.
